| Companies sponsors |
GlaxoSmithKline (dostarlimab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
None |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| Associated public health groups |
None |
| Comparator companies |
AstraZeneca (durvalumab, olaparib) (confidentiality agreement signed, participating) |
| |
Merck Sharp & Dohme (pembrolizumab) (confidentiality agreement signed, participating) |
| |
Accord (carboplatin, paclitaxel, cisplatin, doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Alliance Healthcare (cyclophosphamide, paclitaxel) (confidentiality agreement not signed, not participating) |
| |
Bausch & Lomb (megestrol acetate) (confidentiality agreement not signed, not participating) |
| |
Baxter Healthcare (cyclophosphamide) (confidentiality agreement not signed, not participating) |
| |
Bristol Myers Squibb Pharmaceuticals (paclitaxel) (confidentiality agreement not signed, not participating) |
| |
Consilient Health (carboplatin) (confidentiality agreement not signed, not participating) |
| |
Fresenius Kabi (carboplatin, paclitaxel) (confidentiality agreement not signed, not participating) |
| |
Hospira UK (carboplatin, paclitaxel) (confidentiality agreement not signed, not participating) |
| |
Johnson & Johnson Innovative Medicine (doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Medac GmbH (doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Novartis (cisplatin, cyclophosphamide) (confidentiality agreement not signed, not participating) |
| |
Pfizer (carboplatin, paclitaxel, cisplatin, doxorubicin, medroxyprogesterone acetate) (confidentiality agreement not signed, not participating) |
| |
Sandoz (cyclophosphamide) (confidentiality agreement not signed, not participating) |
| |
Seacross Pharmaceuticals (paclitaxel, doxorubicin) (confidentiality agreement not signed, not participating) |
| |
Teva UK (carboplatin, paclitaxel) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| Relevant research groups |
Institute of Cancer Research |